Jailendra Singh
Stock Analyst at Truist Securities
(0.88)
# 3,779
Out of 4,931 analysts
182
Total ratings
26.32%
Success rate
-23.06%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Maintains: Buy | $187 → $234 | $158.27 | +47.85% | 10 | Jul 25, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $298 → $436 | $425.96 | +2.36% | 5 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $209 → $235 | $178.97 | +31.31% | 16 | Jul 23, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $33.53 | +52.10% | 3 | Jul 17, 2025 | |
| PGNY Progyny | Maintains: Hold | $24 → $27 | $23.07 | +17.04% | 10 | Jul 17, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $45 → $48 | $51.15 | -6.16% | 10 | Jul 17, 2025 | |
| EVH Evolent Health | Maintains: Buy | $14 → $16 | $9.62 | +66.32% | 6 | Jul 17, 2025 | |
| DOCS Doximity | Maintains: Hold | $52 → $61 | $58.24 | +4.74% | 9 | Jul 17, 2025 | |
| HNGE Hinge Health | Initiates: Buy | $48 | $59.99 | -19.99% | 1 | Jun 16, 2025 | |
| PHR Phreesia | Maintains: Buy | $34 → $35 | $26.75 | +30.87% | 6 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $6.92 | +30.15% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $19.57 | +43.11% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $3.39 | +62.24% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $7.46 | +0.54% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $21.51 | +113.85% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $277.10 | -24.22% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $12.38 | +13.13% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $0.84 | +670.96% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $3.65 | +256.16% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $6.35 | +577.17% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $3.91 | +513.81% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $1.84 | +117.39% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $153.31 | -62.17% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $5.77 | +679.90% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $662.53 | -49.74% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.22 | +306.32% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $22.31 | - | 3 | Jan 15, 2021 |
ICON Public Limited Company
Jul 25, 2025
Maintains: Buy
Price Target: $187 → $234
Current: $158.27
Upside: +47.85%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $298 → $436
Current: $425.96
Upside: +2.36%
IQVIA Holdings
Jul 23, 2025
Maintains: Buy
Price Target: $209 → $235
Current: $178.97
Upside: +31.31%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $33.53
Upside: +52.10%
Progyny
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $23.07
Upside: +17.04%
Hims & Hers Health
Jul 17, 2025
Maintains: Hold
Price Target: $45 → $48
Current: $51.15
Upside: -6.16%
Evolent Health
Jul 17, 2025
Maintains: Buy
Price Target: $14 → $16
Current: $9.62
Upside: +66.32%
Doximity
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $58.24
Upside: +4.74%
Hinge Health
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $59.99
Upside: -19.99%
Phreesia
May 29, 2025
Maintains: Buy
Price Target: $34 → $35
Current: $26.75
Upside: +30.87%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $6.92
Upside: +30.15%
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $19.57
Upside: +43.11%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $3.39
Upside: +62.24%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $7.46
Upside: +0.54%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $21.51
Upside: +113.85%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $277.10
Upside: -24.22%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $12.38
Upside: +13.13%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $0.84
Upside: +670.96%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $3.65
Upside: +256.16%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $6.35
Upside: +577.17%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $3.91
Upside: +513.81%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $1.84
Upside: +117.39%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $153.31
Upside: -62.17%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $5.77
Upside: +679.90%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $662.53
Upside: -49.74%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.22
Upside: +306.32%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $22.31
Upside: -